Related Experiment Videos
[Liver transplantation in hepatocellular carcinoma: new developments]
1Klinik für Allgemein-, Viszeral- und Transplantations-chirurgie, Charité-Campus Virchow-Klinikum, Humboldt Universität Berlin.
Praxis
|September 18, 2002
Summary
Liver transplantation offers a cure for cirrhosis and hepatocellular carcinoma (HCC). Patient selection, focusing on tumor size and grade, is key to successful outcomes and survival rates.
Area of Science:
- Hepatology
- Surgical Oncology
- Transplant Surgery
Context:
- Liver transplantation is the sole curative option for simultaneous treatment of cirrhosis and hepatocellular carcinoma (HCC).
- Patient selection is critical for determining outcomes after liver transplantation.
- Current criteria for HCC in liver transplantation often include a maximum tumor diameter of 5 cm and up to 3 tumor nodes.
Purpose:
- To evaluate the prognostic significance of histopathological grading and vascular invasion in patients undergoing liver transplantation for HCC.
- To assess the survival rates and recurrence risks associated with liver transplantation for small HCC in cirrhotic patients.
Summary:
- Liver transplantation for small HCC in cirrhotic patients achieves 5- and 10-year survival rates of 70% and 60%, respectively.
- Low postoperative mortality, tumor recurrence, and reduced cirrhosis-related mortality contribute to favorable outcomes.
- Vascular invasion and histopathological grading are significant risk factors for patient survival and vascular invasion, respectively.
Impact:
- Identifies histopathological grading as the most crucial factor for predicting vascular invasion.
- Highlights the importance of precise patient selection criteria for optimizing liver transplant outcomes in HCC.
- Provides evidence supporting the efficacy of liver transplantation in managing HCC within the context of cirrhosis.